Psykey, Inc. (CEOS)
USD 0.01
(-2.2%)
USD 0.01
(-2.2%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.21 Million USD | 230.6% |
| 2022 | 367.05 Thousand USD | 10.67% |
| 2021 | 331.66 Thousand USD | 0.0% |
| 2020 | - USD | -100.0% |
| 2019 | 4329.00 USD | 225.73% |
| 2018 | 1329.00 USD | 0.0% |
| 2016 | 1.23 Million USD | 17.39% |
| 2015 | 1.05 Million USD | -44.98% |
| 2014 | 1.91 Million USD | 0.0% |
| 2007 | 9.54 Million USD | -15.24% |
| 2006 | 11.26 Million USD | 43615.56% |
| 2005 | 25.77 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q4 | 490.86 Thousand USD | 30.17% |
| 2023 FY | 1.21 Million USD | 230.6% |
| 2023 Q3 | 377.1 Thousand USD | 63.72% |
| 2023 Q1 | 115.18 Thousand USD | 2.62% |
| 2023 Q2 | 230.33 Thousand USD | 99.97% |
| 2022 FY | 367.05 Thousand USD | 10.67% |
| 2022 Q3 | 90.34 Thousand USD | 8.11% |
| 2022 Q4 | 112.23 Thousand USD | 24.24% |
| 2022 Q1 | 80.91 Thousand USD | -70.81% |
| 2022 Q2 | 83.56 Thousand USD | 3.27% |
| 2021 Q4 | 277.22 Thousand USD | 905.51% |
| 2021 FY | 331.66 Thousand USD | 0.0% |
| 2021 Q1 | 12.1 Thousand USD | 0.0% |
| 2021 Q2 | 14.76 Thousand USD | 21.97% |
| 2021 Q3 | 27.57 Thousand USD | 86.8% |
| 2020 FY | - USD | -100.0% |
| 2019 FY | 4329.00 USD | 225.73% |
| 2018 FY | 1329.00 USD | 0.0% |
| 2016 FY | 1.23 Million USD | 17.39% |
| 2015 FY | 1.05 Million USD | -44.98% |
| 2014 FY | 1.91 Million USD | 0.0% |
| 2008 Q2 | 476.77 Thousand USD | -45.6% |
| 2008 Q3 | 2.24 Million USD | 370.55% |
| 2008 Q1 | 876.34 Thousand USD | -33.56% |
| 2007 Q2 | -2.88 Million USD | -212.61% |
| 2007 Q3 | 2.78 Million USD | 196.78% |
| 2007 Q1 | 2.55 Million USD | -29.08% |
| 2007 Q4 | 1.31 Million USD | -52.71% |
| 2007 FY | 9.54 Million USD | -15.24% |
| 2006 Q3 | 1.92 Million USD | -50.17% |
| 2006 FY | 11.26 Million USD | 43615.56% |
| 2006 Q4 | 3.6 Million USD | 87.63% |
| 2006 Q1 | 1.83 Million USD | 0.0% |
| 2006 Q2 | 3.85 Million USD | 110.76% |
| 2005 FY | 25.77 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | 57.62% |
| Ansell Limited | 495.5 Million USD | 99.755% |
| Ansell Limited | 495.5 Million USD | 99.755% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | 98.535% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | 29.887% |
| ConvaTec Group Plc | 910.31 Million USD | 99.867% |
| ConvaTec Group Plc | 872.5 Million USD | 99.861% |
| Encision Inc. | 3.77 Million USD | 67.87% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -755.702% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -1003.856% |
| Innovative MedTech Inc. | 6.09 Million USD | 80.104% |
| LifePoint, Inc. | 7.42 Million USD | 83.654% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | 80.887% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -41.927% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -67.115% |
| Reflect Scientific, Inc. | 1.06 Million USD | -14.081% |
| SmileDirectClub, Inc. | 517 Million USD | 99.765% |
| Sector 10, Inc. | 39.84 Thousand USD | -2945.578% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | 99.982% |
| SheerVision, Inc. | 2.33 Million USD | 47.956% |
| United Health Products, Inc. | 2.42 Million USD | 49.991% |
| Vasamed, Inc. | 4.67 Million USD | 74.032% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | 52.632% |
| Yubo International Biotech Limited | 1.25 Million USD | 3.529% |